U.S. Trade Action Targets German Pharmaceutical Pricing Reforms
The United States has initiated a formal trade investigation under Section 301 of the Trade Act of 1974 into Germany's proposed legislative changes aimed at reducing drug development expenditures. U.S. Trade Representative Jamieson Greer announced the probe on Thursday, citing concerns that the German measures may discriminate against or harm U.S. …